165 related articles for article (PubMed ID: 12755490)
1. The 17q23 amplicon and breast cancer.
Sinclair CS; Rowley M; Naderi A; Couch FJ
Breast Cancer Res Treat; 2003 Apr; 78(3):313-22. PubMed ID: 12755490
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer.
Monni O; Barlund M; Mousses S; Kononen J; Sauter G; Heiskanen M; Paavola P; Avela K; Chen Y; Bittner ML; Kallioniemi A
Proc Natl Acad Sci U S A; 2001 May; 98(10):5711-6. PubMed ID: 11331760
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells.
Erson AE; Niell BL; DeMers SK; Rouillard JM; Hanash SM; Petty EM
Neoplasia; 2001; 3(6):521-6. PubMed ID: 11774034
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors.
Wu G; Sinclair C; Hinson S; Ingle JN; Roche PC; Couch FJ
Cancer Res; 2001 Jul; 61(13):4951-5. PubMed ID: 11431322
[TBL] [Abstract][Full Text] [Related]
5. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions.
Bärlund M; Tirkkonen M; Forozan F; Tanner MM; Kallioniemi O; Kallioniemi A
Genes Chromosomes Cancer; 1997 Dec; 20(4):372-6. PubMed ID: 9408753
[TBL] [Abstract][Full Text] [Related]
6. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.
Sinclair CS; Adem C; Naderi A; Soderberg CL; Johnson M; Wu K; Wadum L; Couch VL; Sellers TA; Schaid D; Slezak J; Fredericksen Z; Ingle JN; Hartmann L; Jenkins RB; Couch FJ
Cancer Res; 2002 Jul; 62(13):3587-91. PubMed ID: 12097257
[TBL] [Abstract][Full Text] [Related]
7. High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer.
Pärssinen J; Kuukasjärvi T; Karhu R; Kallioniemi A
Br J Cancer; 2007 Apr; 96(8):1258-64. PubMed ID: 17353917
[TBL] [Abstract][Full Text] [Related]
8. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.
Bärlund M; Monni O; Kononen J; Cornelison R; Torhorst J; Sauter G; Kallioniemi OLLI-P ; Kallioniemi A
Cancer Res; 2000 Oct; 60(19):5340-4. PubMed ID: 11034067
[TBL] [Abstract][Full Text] [Related]
9. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
[TBL] [Abstract][Full Text] [Related]
10. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
[TBL] [Abstract][Full Text] [Related]
11. Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers.
Willis S; Hutchins AM; Hammet F; Ciciulla J; Soo WK; White D; van der Spek P; Henderson MA; Gish K; Venter DJ; Armes JE
Genes Chromosomes Cancer; 2003 Apr; 36(4):382-92. PubMed ID: 12619162
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the chromosome 17q23 amplicon and breast cancer risk.
Kelemen LE; Wang X; Fredericksen ZS; Pankratz VS; Pharoah PD; Ahmed S; Dunning AM; Easton DF; Vierkant RA; Cerhan JR; Goode EL; Olson JE; Couch FJ
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1864-8. PubMed ID: 19454617
[TBL] [Abstract][Full Text] [Related]
13. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.
Ray ME; Yang ZQ; Albertson D; Kleer CG; Washburn JG; Macoska JA; Ethier SP
Cancer Res; 2004 Jan; 64(1):40-7. PubMed ID: 14729606
[TBL] [Abstract][Full Text] [Related]
14. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
Garcia MJ; Pole JC; Chin SF; Teschendorff A; Naderi A; Ozdag H; Vias M; Kranjac T; Subkhankulova T; Paish C; Ellis I; Brenton JD; Edwards PA; Caldas C
Oncogene; 2005 Aug; 24(33):5235-45. PubMed ID: 15897872
[TBL] [Abstract][Full Text] [Related]
15. 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes.
Wu GJ; Sinclair CS; Paape J; Ingle JN; Roche PC; James CD; Couch FJ
Cancer Res; 2000 Oct; 60(19):5371-5. PubMed ID: 11034073
[TBL] [Abstract][Full Text] [Related]
16. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
[TBL] [Abstract][Full Text] [Related]
17. Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.
Bièche I; Tomasetto C; Régnier CH; Moog-Lutz C; Rio MC; Lidereau R
Cancer Res; 1996 Sep; 56(17):3886-90. PubMed ID: 8752152
[TBL] [Abstract][Full Text] [Related]
18. High-resolution genomic and expression analyses of copy number alterations in breast tumors.
Haverty PM; Fridlyand J; Li L; Getz G; Beroukhim R; Lohr S; Wu TD; Cavet G; Zhang Z; Chant J
Genes Chromosomes Cancer; 2008 Jun; 47(6):530-42. PubMed ID: 18335499
[TBL] [Abstract][Full Text] [Related]
19. Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines.
Yang ZQ; Albertson D; Ethier SP
Cancer Genet Cytogenet; 2004 Nov; 155(1):57-62. PubMed ID: 15527903
[TBL] [Abstract][Full Text] [Related]
20. PPM1D is a potential target for 17q gain in neuroblastoma.
Saito-Ohara F; Imoto I; Inoue J; Hosoi H; Nakagawara A; Sugimoto T; Inazawa J
Cancer Res; 2003 Apr; 63(8):1876-83. PubMed ID: 12702577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
